EPO reengineered to cross mice BBB for neuroprotection
Reengineering erythropoietin (EPO) as an immunoglobulin G (IgG) fusion protein enables penetration of the blood-brain barrier (BBB) in mice, according to researchers.
Archives for September 22, 2010
DSM seeks Asian partners; welcomes J&J Crucell takeover
DSM aims to keep pace with the rapid evolution of pharmaceutical sector through increased partnering and a focus on Asia.